Literature DB >> 33477819

Cost Analysis of Selected Radiotherapeutic Modalities for Prostate Cancer Treatment-Czech Republic Case Study for the Purposes of Hospital Based HTA.

Petra Hospodková1, Tomáš Husár2, Barbora Klíčová2, Lucie Severová1, Karel Šrédl1, Roman Svoboda1.   

Abstract

This study aims to calculate the costs of prostate cancer radiotherapy in a regional hospital Department of Radiation Oncology equipped with Three-Dimensional Conformal Radiation Therapy (3D-CRT) and Intensity Modulated Radiation Therapy (IMRT) Volumetric Arc Therapy (VMAT) radiation technology, using activity based costing (ABC), and to compare the costs of both methods at the level of component treatment process activities and with respect to insurance reimbursements. The costing was performed based on a sample of 273 IMRT VMAT patients and 312 3D-CRT patients in a regional hospital in the period from 2018 to 2019. The research has highlighted the necessity to place emphasis on factors that may skew the costing results. The resulting output has been supplemented by a sensitivity analysis, whereas the modeled parameter is represented by the time required for one patient fraction on a linear accelerator and the time the Radiology Assistant needs to prepare the complete radiation plan as part of radiotherapy planning. Moreover, the effects of the received grant, in the form of calculated write-offs, are also considered. The case study uses the example of radiotherapy to demonstrate the potential of ABC and suggests considering the application of this method as an effective management tool for cost and economic evaluation as part of comprehensive hospital assessment under the Hospital-Based Health Technology Assessment (HB-HTA) initiative.

Entities:  

Keywords:  3D-CRT; IMRT; activity based costing; prostate cancer; sensitivity analysis

Year:  2021        PMID: 33477819      PMCID: PMC7832912          DOI: 10.3390/healthcare9010098

Source DB:  PubMed          Journal:  Healthcare (Basel)        ISSN: 2227-9032


  28 in total

Review 1.  Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer.

Authors:  A T Zemplényi; Z Kaló; G Kovács; R Farkas; T Beöthe; D Bányai; Z Sebestyén; D Endrei; I Boncz; L Mangel
Journal:  Eur J Cancer Care (Engl)       Date:  2016-01-19       Impact factor: 2.520

2.  Activity-based costing for hospitals.

Authors:  S Udpa
Journal:  Health Care Manage Rev       Date:  1996

3.  The cost of radiotherapy in a decade of technology evolution.

Authors:  Evelyn Van de Werf; Jan Verstraete; Yolande Lievens
Journal:  Radiother Oncol       Date:  2011-08-26       Impact factor: 6.280

4.  Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing.

Authors:  Matthew S Ning; Ann H Klopp; Anuja Jhingran; Lilie L Lin; Patricia J Eifel; Sastry Vedam; Ann A Lawyer; Nicholas D Olivieri; Alexis B Guzman; James R Incalcaterra; Shane M Mesko; Todd A Pezzi; David R Boyce-Fappiano; Simona F Shaitelman; Steven J Frank; Nikhil G Thaker
Journal:  Brachytherapy       Date:  2019-04-13       Impact factor: 2.362

5.  Integral dose: Comparison between four techniques for prostate radiotherapy.

Authors:  Krzysztof Ślosarek; Wojciech Osewski; Aleksandra Grządziel; Michał Radwan; Łukasz Dolla; Marta Szlag; Małgorzata Stąpór-Fudzińska
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-18

Review 6.  Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.

Authors:  Florian Rudolf Schroeck; Bruce L Jacobs; Sam B Bhayani; Paul L Nguyen; David Penson; Jim Hu
Journal:  Eur Urol       Date:  2017-03-31       Impact factor: 20.096

7.  Cost of prostate image-guided radiation therapy: results of a randomized trial.

Authors:  Lionel Perrier; Magali Morelle; Pascal Pommier; Jean-Léon Lagrange; Agnès Laplanche; Philippe Dudouet; Stéphane Supiot; Bruno Chauvet; Tan-Dat Nguyen; Gilles Crehange; Véronique Beckendorf; Françoise Pene; Xavier Muracciole; Jean-Marc Bachaud; Elisabeth Le Prisé; Renaud de Crevoisier
Journal:  Radiother Oncol       Date:  2013-01-17       Impact factor: 6.280

8.  Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.

Authors:  Martin C S Wong; William B Goggins; Harry H X Wang; Franklin D H Fung; Colette Leung; Samuel Y S Wong; Chi Fai Ng; Joseph J Y Sung
Journal:  Eur Urol       Date:  2016-06-08       Impact factor: 20.096

Review 9.  Effects and repercussions of local/hospital-based health technology assessment (HTA): a systematic review.

Authors:  Marie-Pierre Gagnon; Marie Desmartis; Thomas Poder; William Witteman
Journal:  Syst Rev       Date:  2014-10-28

Review 10.  Prostate cancer screening in Europe and Asia.

Authors:  Kai Zhang; Chris H Bangma; Monique J Roobol
Journal:  Asian J Urol       Date:  2016-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.